Abstract Library

#258 Diagnosis and Management of Thymic Neuroendocrine Tumors: A Case Series Review

Introduction: Thymic neuroendocrine tumors (TNET) represent rare types of thymic tumors with an incidence of 0.01/100000 per year. They commonly show rapid disease progression and are rarely curable.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Akay E, El-Khouly F, Khan M, Caplin M, Toumpanakis C,

Keywords: thymic, thymic neuroendocrine tumor, radical thymectomy, chemotherapy, somatostatin analogues, Y-90,

#252 Y90-DOTATATE in Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Survival Following Different Indications for Treatment

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an increasingly used treatment for GEP -NETs but there is limited data on indications, efficacy and survival.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Khan M, El-Khouly F, Quigley A, Caplin M, Toumpanakis C,

Keywords: neuroendocrine tumor, radionuclides, survival, therapy,

#251 Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors

Introduction: The recent classification system proposed by ENETS assigns grade by Ki-67 index +/- mitotic count. It has been adopted into routine practice but there is limited data on the relationship between them.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Khan M, El-Khouly F, Toumpanakis C, Meyer T, Caplin M,

Keywords: survival, neuroendocrine tumor, Ki-67, proliferation, biomarker,

#244 Challenges in the Management of VIPoma Patients

Introduction: VIPomas are a rare neuroendocrine tumor (NET). 90% are pancreatic. 40-70% are metastatic at presentation. The VIPoma syndrome is characterized by secretory diarrhoea, hypokalaemia and achlorhydria.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: El-Khouly F, Khan M, Toumpanakis C, Meyer T, Caplin M,

Keywords: VIPoma, VIPoma syndrome,

#243 Morbidity and Mortality Associated with Desmoplasia in Midgut Neuroendocrine Tumors (NETs)

Introduction: The clinical course of midgut NETs may be heavily complicated by problems related to mesenteric desmoplasia, causing symptoms secondary to mesenteric artery/vein occlusion and bowel obstruction.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: El-Khouly F, Khan M, Toumpanakis C, Ogunbiyi O, Winslet M,

Keywords: midgut, neuroendocrine tumors, desmoplasia,